Anna Durrans
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Cancer Genomics and Diagnostics 2
- MicroRNA in disease regulation 2
- Cancer, Hypoxia, and Metabolism 2
- Protease and Inhibitor Mechanisms 1
- Oncology 5
- Cancer Cells and Metastasis 4
- Co-authors
- Hyejin Choi (6 shared papers)Vivek Mittal (6 shared papers)Nasser K. Altorki (6 shared papers)Dingcheng Gao (5 shared papers)Stephen T.C. Wong (4 shared papers)Jianting Sheng (3 shared papers)Fuhai Li (3 shared papers)Seongho Ryu (4 shared papers)
- Journals
- Cancer Research (2 papers)Cell Reports (1 paper)Neoplasia (1 paper)Nature (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesSouth Korea
In The Last Decade
Anna Durrans
7 papers receiving 1.6k citations
Anna Durrans's Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 559
- Oncology 881
- Molecular Biology 897
- Cell Biology 181
- Immunology 158
Countries citing papers authored by Anna Durrans
This map shows the geographic impact of Anna Durrans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Durrans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Durrans more than expected).
Fields of papers citing papers by Anna Durrans
This network shows the impact of papers produced by Anna Durrans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Durrans. The network helps show where Anna Durrans may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Durrans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance Hit paper breakdown → | 2015 | 1410 |
| 2 | 2015 | 120 | |
| 3 | 2016 | 49 | |
| 4 | 2010 | 25 | |
| 5 | 2015 | 15 | |
| 6 | 2015 | 4 | |
| 7 | 2014 | 2 |
About Anna Durrans
Anna Durrans is a scholar working on Cancer Research, Oncology, Molecular Biology, Epidemiology and Cell Biology, having authored 7 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (2 papers), MicroRNA in disease regulation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Zebrafish Biomedical Research Applications (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Epigenetics and DNA Methylation (1 paper) and Protease and Inhibitor Mechanisms (1 paper). The work is most often cited by research in Cancer Research (559 citations), Oncology (881 citations), Molecular Biology (897 citations), Cell Biology (181 citations) and Immunology (158 citations). Anna Durrans has collaborated with scholars based in United States and South Korea. Frequent co-authors include Hyejin Choi, Vivek Mittal, Nasser K. Altorki, Dingcheng Gao, Stephen T.C. Wong, Jianting Sheng, Fuhai Li, Seongho Ryu, Kari Fischer and Tina El Rayes. Their work appears in journals such as Cancer Research, Cell Reports, Neoplasia, Nature and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.